Precigen (PGEN) CEO Helen Sabzevari Exercises RSUs; 10,184 Shares Withheld

What Happened

• Helen Sabzevari, President and CEO of Precigen, had 20,833 restricted stock units (RSUs) vest and convert into common shares on August 23, 2026. To satisfy tax withholding, the issuer withheld 10,184 of those shares at $7.20 each (total value $73,325). That leaves a net of about 10,649 shares delivered to her from this vesting event.
• This was not an open-market sale or purchase by the insider; it reflects routine RSU settlement and tax withholding rather than a directional trade.

Key Details

• Transaction date: August 23, 2026.
• RSUs vested/converted: 20,833 shares (1/24 tranche of the June 26, 2025 grant).
• Shares withheld for taxes: 10,184 shares at $7.20 per share, total $73,325 (tax withholding).
• Net shares received by insider from this vesting: ~10,649 shares.
• Footnotes: F1—each RSU represents a right to one share; F2—withheld shares satisfy income tax withholding; F3—this tranche is 1/24 of the RSUs granted 6/26/2025 and vested 8/23/2026.
• Shares owned after the transaction: not specified in the Form 4 filing.
• Filing timeliness: Form filed Aug 25, 2026 for an Aug 23 transaction; this appears to be a routine filing (not indicated as late in the report).

Context

• This was a settlement of RSUs (an award), not a market sale—the withholding is a common cashless method to meet tax obligations when equity awards vest.
• Such insider vesting and withholding filings are routine and do not necessarily signal the insider’s view of the company’s stock.